US Broker Ratings

Pfizer, Inc. (PFE)

⚠️ No article content returned.

..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Potential 45.6% Upside and Strong Buy Ratings

Investors eyeing opportunities in the healthcare sector might find Prestige Consumer Healthcare Inc. (NYSE: PBH) a compelling prospect. With a market capitalization of $2.49 billion, this U.S.-based company operates in..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a Potential 34% Upside Amidst Current Market Dynamics

Investors seeking opportunities in the healthcare sector may find Grifols, S.A. (NASDAQ: GRFS) an intriguing prospect. With its headquarters in Barcelona, Spain, Grifols is a key player in the drug..

HealthEquity, Inc. (HQY) Stock Analysis: 33% Potential Upside with Strong Buy Ratings

HealthEquity, Inc. (NASDAQ: HQY), a leading player in the health information services sector, is catching the attention of investors with a potential upside of 33.04%, according to analyst ratings. With..

Alkermes plc (ALKS) Stock Analysis: Exploring a 30% Potential Upside with Robust Revenue Growth

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector specializing in drug manufacturing, presents a compelling case for investors with its significant potential upside and impressive revenue growth..

Molina Healthcare Inc (MOH) Stock Analysis: Understanding the Investment Dynamics Amidst a Challenging Sector

Investors eyeing Molina Healthcare Inc (NYSE: MOH) must navigate a landscape marked by mixed signals. As a prominent player in the healthcare plans industry, Molina Healthcare serves a critical role..

Merit Medical Systems (MMSI) Stock Analysis: A Promising 47.93% Potential Upside

Investors looking to navigate the dynamic healthcare sector may find Merit Medical Systems, Inc. (NASDAQ: MMSI) an intriguing option. With a promising potential upside of 47.93%, this Utah-based medical instruments..

STERIS plc (STE) Stock Analysis: Navigating a 34.63% Potential Upside in the Medical Devices Sector

Investors with an eye on the healthcare sector should take notice of STERIS plc (NYSE: STE), a prominent player in the medical devices industry. With a market capitalization of $20.36..

Abbott Laboratories (ABT) Stock Analysis: Strong Buy Ratings Signal Potential 40.7% Upside

Abbott Laboratories (NYSE: ABT), a titan in the healthcare sector, is capturing investor attention with its promising potential upside of 40.7%, as indicated by the average target price of $118.64..

Globus Medical, Inc. (GMED) Stock Analysis: Exploring a 43% Potential Upside in the Medical Device Sector

For investors keen on the healthcare sector, particularly within medical devices, Globus Medical, Inc. (NYSE: GMED) presents a compelling opportunity. With a market capitalization of $10.58 billion, this Pennsylvania-based company..

ADMA Biologics Inc (ADMA) Stock Analysis: Unpacking the 105% Potential Upside

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the healthcare sector, specifically within the biotechnology industry, presents an intriguing opportunity for investors seeking exposure to the burgeoning field of..

RadNet, Inc. (RDNT) Stock Analysis: Unpacking a 54% Upside Potential in the Booming Diagnostics Sector

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare sector, is capturing the attention of investors with its substantial upside potential. With a market capitalization of $4.55 billion, RadNet..

Glaukos Corporation (GKOS) Stock Analysis: A 13.15% Upside Potential in the Medical Devices Sector

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector, specializes in developing innovative medical devices for ophthalmic applications. With a market capitalization of $7.84 billion, Glaukos is a..

TG Therapeutics, Inc. (TGTX) Investor Outlook: Strong Buy Ratings and Potential 12.33% Upside

TG Therapeutics, Inc. (NASDAQ: TGTX), a prominent player in the healthcare sector, is making waves in the biotechnology industry with its innovative approach to treating B-cell mediated diseases. Headquartered in..

Legend Biotech Corporation (LEGN): Investor Outlook with a Promising 103% Potential Upside

Legend Biotech Corporation (NASDAQ: LEGN) is capturing investor attention with its significant potential upside, currently estimated at 103.54%. As a noteworthy player in the biotechnology sector, Legend Biotech is reinforcing..

Lantheus Holdings, Inc. (LNTH): An Investor’s Perspective on its 9.94% Potential Upside

Lantheus Holdings, Inc. (NASDAQ: LNTH) is a notable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $6.06 billion, Lantheus..

West Pharmaceutical Services (WST) Stock Analysis: A 7.34% Upside in the Healthcare Sector

West Pharmaceutical Services, Inc. (NYSE: WST), a leading player in the healthcare sector, is capturing the attention of investors with its robust market position and a promising potential upside of..

ICON plc (ICLR) Stock Analysis: Strong Buy Ratings and 10% Upside Potential

ICON plc (ICLR), a prominent player in the healthcare sector, especially within the diagnostics and research industry, presents an intriguing opportunity for investors seeking a foothold in the clinical research..

Elanco Animal Health (ELAN) Stock Analysis: Exploring a Potential 26% Upside in the Animal Health Sector

Elanco Animal Health Incorporated (NYSE: ELAN), a prominent player in the healthcare sector focused on drug manufacturing for specialty and generic markets, presents an intriguing opportunity for investors. With a..

Boston Scientific Corporation (BSX) Stock Analysis: A Promising 57.96% Potential Upside

Boston Scientific Corporation (NYSE: BSX), a leader in the healthcare sector specializing in medical devices, is capturing investor attention with a compelling 57.96% potential upside. With a market capitalization of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds